Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.
Kwadwo AntwiMelpomeni FaniTobias HeyeGuillaume NicolasChristof RottenburgerFelix KaulElmar MerkleChristoph J ZechDaniel BollDeborah R VogtBeat GloorEmanuel ChristDamian WildPublished in: European journal of nuclear medicine and molecular imaging (2018)
68Ga-DOTA-exendin-4 PET/CT performed significantly better than 111In-DOTA-exendin-4 SPECT/CT and MRI in the localisation of benign insulinomas and should be considered in patients where localisation fails with CT/MRI ( ClinicalTrials.gov , NCT02127541).
Keyphrases
- pet ct
- contrast enhanced
- magnetic resonance imaging
- positron emission tomography
- computed tomography
- magnetic resonance
- diffusion weighted imaging
- dual energy
- end stage renal disease
- image quality
- ejection fraction
- chronic kidney disease
- newly diagnosed
- high resolution
- peritoneal dialysis
- prognostic factors
- open label
- patient reported outcomes
- mass spectrometry
- photodynamic therapy